![Adrian Kilcoyne](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Adrian Kilcoyne
Directeur Technique/Scientifique/R&D chez
CELLECTIS S.A.
Fortune : 296 137 $ au 31/05/2026
Profil
Adrian Kilcoyne currently works at Cellectis SA, as Chief Medical Officer from 2024.
Dr. Kilcoyne also formerly worked at AstraZeneca PLC, as VP, Head-US Medical Affairs & Health Economics, Humanigen, Inc., as Chief Medical Officer from 2021 to 2022, and Celularity, Inc., as Chief Medical Officer & Executive Vice President from 2022 to 2024.
Dr. Kilcoyne received his graduate degree from Warwick Business School, graduate degree from the University of London, and doctorate degree from Trinity College Dublin.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CELLECTIS S.A. 0,11% | 15/02/2026 | 82 500 ( 0,11% ) | 296 137 $ | 31/05/2026 |
Postes actifs de Adrian Kilcoyne
| Sociétés | Poste | Début |
|---|---|---|
| CELLECTIS S.A. | Directeur Technique/Scientifique/R&D | 07/08/2024 |
Anciens postes connus de Adrian Kilcoyne
| Sociétés | Poste | Fin |
|---|---|---|
| CELULARITY INC. | Directeur Technique/Scientifique/R&D | 06/08/2024 |
| HUMANIGEN, INC. | Directeur Technique/Scientifique/R&D | 28/09/2022 |
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Formation de Adrian Kilcoyne
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
7
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Humanigen, Inc.
 Humanigen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in development of cell and gene therapies for treatment of cancers and infectious diseases | Health Technology |
Warwick Business School
 Warwick Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trinity College Dublin
 Trinity College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellectis SA
 Cellectis SA Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapies | Health Technology |
Celularity, Inc.
 Celularity, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotechnology company that discovers cancer sub-types and therapeutic options for cancer patients | Commercial Services |
Choisissez Zonebourse 
